Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis [1]
Transcatheter AVR (TAVR) was compared to surgical AVR for treatment of aortic stenosis in 795 high risk patients. TAVR was associated with a decreased risk of death at 1 year (14% vs 19%; p<0.04). This was likely due to a reduction in the risk of adverse cardiovascular and cerebrovascular events.
Source name:
New England Journal of Medicine
Resource link: